Amylyx Pharmaceuticals Inc

General ticker "AMLX" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $329.0M

Amylyx Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -19.8%.

Estimated limits based on current volatility of 3.5%: low 3.92$, high 4.21$

Factors to consider:

  • Current price 18.4% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [5.00$, 12.88$]
  • 2024-12-30 to 2025-12-30 estimated range: [3.70$, 9.27$]

Financial Metrics affecting the AMLX estimates:

  • Positive: 0.10 < Non-GAAP EPS, $ of 0.70
  • Negative: Operating cash flow per share per price, % of 1.25 <= 2.35
  • Positive: 9.05 < Operating profit margin, % of 10.19
  • Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85

Similar symbols

Short-term AMLX quotes

Long-term AMLX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.28MM $22.23MM $380.79MM
Operating Expenses $82.97MM $223.57MM $341.98MM
Operating Income $-82.69MM $-201.34MM $38.80MM
Non-Operating Income $-5.24MM $3.74MM $15.49MM
Interest Expense $0.00MM $4.29MM $0.00MM
R&D Expense $44.04MM $93.45MM $128.19MM
Income(Loss) $-87.93MM $-197.60MM $54.30MM
Taxes $-0.05MM $0.77MM $5.03MM
Profit(Loss) $-87.88MM $-198.38MM $49.27MM
Stockholders Equity $-151.17MM $340.61MM $433.43MM
Inventory $0.00MM $9.77MM $38.32MM
Assets $105.61MM $391.45MM $517.45MM
Operating Cash Flow $-74.80MM $-179.87MM $11.92MM
Capital expenditure $0.35MM $2.53MM $1.24MM
Investing Cash Flow $-46.41MM $-238.99MM $92.05MM
Financing Cash Flow $158.51MM $431.79MM $3.54MM
Earnings Per Share* $-1.52 $-2.98 $0.73

* EPS are Split Adjusted, recent splits may be reflected with a delay.